Skip to main content
. 2021 Mar 9;13(3):361. doi: 10.3390/pharmaceutics13030361

Table 5.

Percentage of each curcuminoid in the different formulations administered to Wistar rats.

Formulation CC (%) DMC (%) BDMC (%) Total (%)
NPZ-CC 7.29 1.41 0.48 9.18
Curarti® 14.83 2.85 0.86 18.54
CPC 15.71 3.81 0.48 20.00
Oral Curcuminoid extract 71.71 16.16 6.37 94.24